Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Status:
RECRUITING
Trial end date:
2031-01-01
Target enrollment:
Participant gender:
Summary
This study is an exploratory clinical trial to investigate the feasibility of neoadjuvant chemoimmunotherapy plus extrafascial hysterectomy and pelvic lymph node dissection in patients with stage IB2 (2018 FIGO) cervical cancer and to observe the response rate to treatment, adverse effects and complications, and to assess the survival rate of patients.
Phase:
PHASE2
Details
Lead Sponsor:
Tongji Hospital
Collaborators:
Beijing Friendship Hospital Gansu Provincial Maternal and Child Health Care Hospital Qilu Hospital of Shandong University Shengjing Hospital Sichuan Cancer Hospital and Research Institute Southwest Hospital, China Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial) Tianjin Medical University West China Second University Hospital Women's Hospital School Of Medicine Zhejiang University Xiangya Hospital of Central South University Zhejiang Cancer Hospital